-
Epizyme Inc., Cambridge, Mass. Business: Cancer Date announced: 5/13/13 Type: IPO To be raised: Up to $69 million Shares: 4.3 million Price: TBD Underwriters: Citigroup; Cowen; Leerink; JMP Securities; Wedbush …
Published on 5/20/2013
-
Kamada Ltd. (Tel Aviv:KMDA), Ness Ziona, Israel Business: Pulmonary Date announced: 5/15/13 Type: Follow-on To be raised: About $60 million Shares: 5.6 million Underwriters: Morgan Stanley; Jefferies; RBC Capital …
Published on 5/20/2013
-
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), San Diego, Calif. Business: Neurology, Ophthalmic Date completed: 5/15/13 Type: Follow-on Raised: $100 million Shares: 8 million Price: $12.50 Shares after offering: 86.8 …
Published on 5/20/2013
-
Alere Inc. (NYSE:ALR), Waltham, Mass. Business: Diagnostic Date completed: 5/13/13 Type: Private placement of senior notes Raised: $425 million Investors: Institutional investors Note: The subordinated unsecured notes …
Published on 5/20/2013
-
Alimera Sciences Inc. (NASDAQ: ALIM), Alpharetta, Ga. Business: Ophthalmic Date completed: 5/8/13 Type: Debt financing Raised: $5 million Investor: Silicon Valley Bank Note: The term loan bears 7.5% interest and matures…
Published on 5/20/2013
-
Ambit Biosciences Corp. (NASDAQ: AMBI), San Diego, Calif. Business: Cancer, Autoimmune, Inflammation Date completed: 5/16/13 Type: IPO Raised: $65 million Shares: 8.1 million Price: $8 Shares after offering: 17.7 …
Published on 5/20/2013
-
Ambit Biosciences Corp. (NASDAQ: AMBI), San Diego, Calif. Business: Cancer, Autoimmune, Inflammation Date completed: 5/16/13 Type: Private placement Raised: $25.1 million Shares: 3.1 million Price: $8 Investors: …
Published on 5/20/2013
-
BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 4/10/13 Type: Private placement of common stock and warrants Raised: $5 million Shares: 810,000 Price: $3.70 …
Published on 5/20/2013
-
Callidus Biopharma Inc., Doylestown, Pa. Business: Endocrine/Metabolic Date completed: 5/14/13 Type: Venture financing Raised: $4.6 million
Published on 5/20/2013
-
Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Berkeley Heights, N.J. Business: Cancer Date completed: 5/16/13 Type: Follow-on Raised: $20 million Shares: 6.7 million Price: $3 Shares after offering: 17.5 million …
Published on 5/20/2013
-
Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic Date completed: 5/15/13 Type: Private placement of convertible preferred and common stock Raised: $30 million Shares: 8.9 million Price: $2.…
Published on 5/20/2013
-
ElsaLys Biotech, Lyon, France Business: Antibodies, Cancer, Inflammation Date completed: 5/17/13 Type: Venture financing Raised: 2.1 million ($2.7 million) Investors: Transgene S.A.; Sofimac
Published on 5/20/2013
-
iCo Therapeutics Inc. (TSX-V:ICO), Vancouver, B.C. Business: Ophthalmic, Autoimmune Date completed: 5/10/13 Type: Private placement of units Raised: C$3.4 million ($3.3 million) Units: 9.7 million Price: C$0.35 (unit) …
Published on 5/20/2013
-
Kite Pharma Inc., Los Angeles, Calif. Business: Cancer Date completed: 5/15/13 Type: Venture financing Raised: $20 million Investors: Alta Partners; Pontifax; Commercial Street Capital; company founder; individual …
Published on 5/20/2013
-
Medicago Inc. (TSX:MDG; OTCQX: MDCGF), Quebec, Quebec Business: Infectious, Biomanufacturing Date completed: 4/24/13 Type: Private placement Raised: C$3.5 million ($3.5 million) Shares: 6.3 million Price: C$0.56 Shares …
Published on 5/20/2013
-
MediciNova Inc. (NASDAQ: MNOV), San Diego, Calif. Business: Genitourinary, Inflammation, Neurology Date completed: 5/8/13 Type: Private placement Raised: $3 million Shares: 895,000 Shares after offering: 19.7 million …
Published on 5/20/2013
-
Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Date completed: 5/8/13 Type: Debt financing Raised: $4 million Investor: Platinum Montaur Life Sciences Note: Navidea said in its 1Q13 …
Published on 5/20/2013
-
Omeros Corp. (NASDAQ: OMER), Seattle, Wash. Business: Inflammation, Neurology, Ophthalmic Date completed: 5/14/13 Type: Direct public offering Raised: $16.2 million Shares: 3.9 million Price: $4.14 Shares after offering…
Published on 5/20/2013
-
ReXceptor Inc., Cleveland, Ohio Business: Neurology Date completed: 4/25/13 Type: Venture financing Raised: $1.4 million Investors: Alzheimer's Drug Discovery Foundation; BrightFocus Foundation; Case Western Reserve; …
Published on 5/20/2013
-
Rockwell Medical Technologies Inc. (NASDAQ:RMTI), Wixom, Mich. Business: Renal, Hematology Date completed: 5/15/13 Type: Follow-on Raised: $40.2 million Shares: 13.2 million Price: $3.05 Shares after offering: 39.3 …
Published on 5/20/2013
-
Senesco Technologies Inc. (OTCQB:SNTI), Bridgewater, N.J. Business: Cancer, Autoimmune, Agbio/Environmental Date completed: 5/9/13 Type: Private placement Raised: $1.3 million Shares: 41.8 million Price: $0.03 Shares …
Published on 5/20/2013
-
Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y. Business: Cancer Date completed: 5/16/13 Type: Follow-on Raised: $60 million Shares: 4.1 million Price: $14.50 Shares after offering: 11.7 million Underwriters: …
Published on 5/20/2013
-
Tokai Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Date completed: 5/15/13 Type: Venture financing Raised: $35.5 million Investors: Apple Tree Partners; Novartis Venture Funds; angel investors
Published on 5/20/2013
-
Vermillion Inc. (NASDAQ: VRML), Austin, Texas Business: Diagnostic Date completed: 5/14/13 Type: Private placement of common stock and warrants Raised: $13.2 million Shares: 8 million Price: $1.46 Shares after offering:…
Published on 5/20/2013
-
Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic, Genitourinary, Neurology Date completed: 5/16/13 Type: Private placement of senior convertible notes Raised: $220 million Shares outstanding…
Published on 5/20/2013